Acceptability of Draft Labeling to Support Abbreviated New Drug Application Approval; Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 7, 2015
April 21, 2020
39b1bd86-7931-4b85-b913-e4374ce03b74
Related Documents
Reformulating Drug Products That Contain Carbomers Manufactured With Benzene
Guidance DocumentDecember 28, 2023Center for Drug Evaluation and Research
Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities
Guidance DocumentAugust 7, 2023Center for Drug Evaluation and Research
Development of Monoclonal Antibody Products Targeting SARS-CoV-2 for Emergency Use Authorization
Guidance DocumentDecember 21, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox